Skip to main content
Log in

Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the long-term effects of Floseal® on erectile function recovery (EFR) after nerve-sparing robot-assisted radical prostatectomy (RALP).

Methods

We prospectively collected results of the self-administered International Index Erectile Function Questionnaire 1–5 and 15 (IIEF 1–5 and 15) of 532 consecutive patients who underwent RALP for prostate cancer in our institution between October 2007 and December 2015. Patients were divided into two groups according to Floseal® application after prostatectomy. They were enrolled according to the following criteria: (a) bilateral nerve-sparing procedure; (b) preoperative IIEF ≥ 17; adherence to our erectile rehabilitation protocol; (c) 1-year follow-up. Outcomes were measured as mean IIEF score, EFR (IIEF < 17 or ≥17), grade of ED: severe (IIEF < 17), moderate (17–21), mild (22–25) and no ED (>25).

Results

A total of 120 patients were enrolled. Group A included 40 consecutive patients who received traditional hemostasis, and Group B included 80 consecutive patients in which Floseal® was additionally used. No differences were observed in terms of preoperative mean IIEF score (p = 0.65). Group B patients showed a trend toward a higher mean IIEF score 3 months after surgery (p = 0.06) but no differences in terms of EFR (p = 1.000). Long-term results (6, 9, 12 months after surgery) showed a significantly and progressively higher mean IIEF score (p = 0.04, 0.003, 0.003) and EFR (p = 0.043, 0.027, 0.004) in Group A patients. Comparison between the groups in terms of severe, moderate, mild and no ED becomes significant at 9 and 12 months (p = 0.002, 0.006).

Conclusion

The results of our study suggest that local use of Floseal® worsens the long-term erectile function recovery in patients selected for nerve-sparing RALP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ED:

Erectile dysfunction

EFR:

Erectile function recovery

NVB:

Neurovascular bundles

RALP:

Robot-assisted radical prostatectomy

IIEF:

International Index Erectile Function Questionnaire

References

  1. Tiroli M, Conti A, Muzzonigro G (2012) The use of haemostatic agents in urology. Urologia 79(suppl 19):99–106

    PubMed  Google Scholar 

  2. Achneck HE, Sileshi B, Jamiolkowski RM et al (2010) A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 251:217–228

    Article  PubMed  Google Scholar 

  3. Sileshi B, Achneck HE, Lawson JH (2008) Management of surgical hemostasis: topical agents. Vascular 16(suppl 1):S22–S28

    PubMed  Google Scholar 

  4. David G, Lim S, Gunnarsson C et al (2015) Similar patient outcomes yet different hospital costs between flowable hemostatic agents. J Med Econ 18:735–745

    Article  PubMed  Google Scholar 

  5. Altun I (2016) An experimental study on histopathological effects of hemostatic agents used in spinal surgery. World Neurosurg 90:147–153

    Article  PubMed  Google Scholar 

  6. Rigopoulos C, Kyriazis I, Kallidonis P et al (2013) Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study. BJU Int 112(2):E11421

    Article  Google Scholar 

  7. Cağlar M, Yavuzcan A, Yıldız E et al (2014) Increased adhesion formation after gelatin-thrombin matrix application in a rat model. Arch Gynecol Obstet 290(3):501–506

    Article  PubMed  Google Scholar 

  8. Suzuki Y, Vellinga TT, Istre O et al (2010) Small bowel obstruction associated with use of a gelatin-thrombin matrix sealant (FloSeal) after laparoscopic gynecologic surgery. J Minim Invasive Gynecol 17(5):641–645

    Article  PubMed  Google Scholar 

  9. Thomas PJ, Tawfic SN (2009) Eosinophil-rich inflammatory response to FloSeal hemostatic matrix presenting as postoperative pelvic pain. Am J Obstet Gynecol 200(4):e10–e11

    Article  PubMed  Google Scholar 

  10. Hoffmann NE, Siddiqui SA, Agarwal S et al (2009) Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res 155(1):77–81

    Article  CAS  PubMed  Google Scholar 

  11. Martorana E, Ghaith A, Micali S et al (2016) A retrospective analysis of the hemostatic effect of FloSeal in patients undergoing robot-assisted laparoscopic radical prostatectomy. Urol Int 96(3):274–279

    Article  PubMed  Google Scholar 

  12. Abboudi H, Khan MS, Guru KA et al (2014) Learning curves for urological procedures: a systematic review. BJU Int 114(4):617–629

    Article  PubMed  Google Scholar 

  13. Costello AJ, Brooks M, Cole OJ (2004) Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int 94(7):1071–1076

    Article  PubMed  Google Scholar 

  14. Reeves F, Preece P, Kapoor J et al (2015) Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates: results of a systematic review and meta-analysis. Eur Urol 68(4):692–704

    Article  PubMed  Google Scholar 

  15. Seddon HJ (1942) A classification of nerve injuries. Br Med J 2(4260):237–239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Sunderland S (1981) The anatomic foundation of peripheral nerve repair techniques. Orthop Clin North Am 12(2):245–266

    CAS  PubMed  Google Scholar 

  17. Lee SK, Wolfe SW (2000) Peripheral nerve injury and repair. J Am Acad Orthop Surg 8(4):243–252

    Article  CAS  PubMed  Google Scholar 

  18. Ong AM, Su LM, Varkarakis I et al (2004) Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model. J Urol 172(4 Pt 1):1318–1322

    Article  PubMed  Google Scholar 

  19. Zeltser I, Dugi D, Gupta A et al (2008) Does topical haemostatic agent have an adverse effect on the function of the prostatic neurovascular bundle? BJU Int 102(8):1005–1007

    Article  PubMed  Google Scholar 

  20. Ahlering TE, Eichel L, Skarecky D (2005) Rapid communication: early potency outcomes with cautery-free neurovascular bundle preservation with robotic laparoscopic radical prostatectomy. J Endourol 19:715–718

    Article  PubMed  Google Scholar 

  21. Ahlering TE, Eichel L, Chou D et al (2005) Feasibility study for robotic radical prostatectomy cautery-free neurovascular bundle preservation. Urology 65(994–7):4

    Google Scholar 

  22. Oz MC, Rondinone JF, Shargill NS (2003) FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg 18:486–493

    Article  PubMed  Google Scholar 

  23. Arand AG, Sawaya R (1986) Intraoperative chemical hemostasis in neurosurgery. Neurosurgery 18(2):223–233

    Article  CAS  PubMed  Google Scholar 

  24. Nishino A, Suzuki M, Ohtani H et al (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167–179

    Article  CAS  PubMed  Google Scholar 

  25. Mandel P, Preisser F, Graefen M et al (2016) High Chance of late recovery of urinary and erectile function beyond 12 months after radical prostatectomy. Eur Urol 71(6):848–850

    Article  PubMed  Google Scholar 

  26. Akassoglou K, Akpinar P, Murray S et al (2003) Fibrin is a regulator of Schwann cell migration after sciatic nerve injury in mice. Neurosci Lett 338(3):185–188

    Article  CAS  PubMed  Google Scholar 

  27. Lee P, Spector JG, Derby A et al (1998) Effects of thrombin and protease nexin-1 on peripheral nerve regeneration. Ann Otol Rhinol Laryngol. 107(1):61–69

    Article  CAS  PubMed  Google Scholar 

  28. Lee DY, Park KW, Jin BK (2006) Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun 346(3):727–738

    Article  CAS  PubMed  Google Scholar 

  29. Turgeon VL, Milligan CE, Houenou LJ (1999) Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp Neurol 58(5):499–504

    Article  CAS  PubMed  Google Scholar 

  30. Fujimoto S, Katsuki H, Kume T et al (2006) Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol Dis 22(1):130–142

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giacomo Maria Pirola.

Ethics declarations

Conflict of interest

Authors declare that they do not have any kind of conflict of interest and that they have no affiliations with or involvement in any organization or entity with any financial interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments. All patients signed a specific informed consent before their inclusion into the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martorana, E., Rocco, B., Kaleci, S. et al. Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?. Int Urol Nephrol 49, 1519–1526 (2017). https://doi.org/10.1007/s11255-017-1645-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-017-1645-4

Keywords

Navigation